Neil Martin
- Physiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Immunology and Allergy top 5%
- Immunology
- Surgery
- Co-authors
- Ian PavordJean‐Pierre LlanosDavid HalpinDavid A. LipsonJ. ChirasRobert A. WiseFernando J. MartínezAndrew Menzies‐Gow
- Topics
- Asthma and respiratory diseases (47 papers)Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers)Respiratory and Cough-Related Research (15 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Neil Martin
60 papers receiving 987 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Physiology 646
- Pulmonary and Respiratory Medicine 581
- Immunology and Allergy 131
- Immunology 125
- Surgery 120
Countries citing papers authored by Neil Martin
This map shows the geographic impact of Neil Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Martin more than expected).
Fields of papers citing papers by Neil Martin
This network shows the impact of papers produced by Neil Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Martin. The network helps show where Neil Martin may publish in the future.
Co-authorship network of co-authors of Neil Martin
This figure shows the co-authorship network connecting the top 25 collaborators of Neil Martin. A scholar is included among the top collaborators of Neil Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Martin. Neil Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 5 | |
| 3 | 19 | |
| 4 | 7 | |
| 5 | 19 | |
| 6 | 30 | |
| 7 | 1 | |
| 8 | Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trialsbreakdown → | 95 |
| 9 | 8 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 46 | |
| 13 | 7 | |
| 14 | 71 | |
| 15 | 20 | |
| 16 | 146 | |
| 17 | 26 | |
| 18 | 23 | |
| 19 | 33 | |
| 20 | 2 |
About Neil Martin
Neil Martin is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine, having authored 62 papers that have together received 1.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (47 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers) and Respiratory and Cough-Related Research (15 papers). The work is most often cited by research in Physiology (646 citations), Immunology and Allergy (131 citations) and Pulmonary and Respiratory Medicine (581 citations). Neil Martin has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Ian Pavord, Jean‐Pierre Llanos, David Halpin, David A. Lipson, J. Chiras, Robert A. Wise, Fernando J. Martínez, Andrew Menzies‐Gow, Mark T. Dransfield and Dave Singh. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.